Vegfc-Vegfr3-Dependent Lymphatic Sprouting Requires Apelin Signaling

This study reveals that Apelin signaling, regulated by Vegfc-Vegfr3 via ERK activation, is an indispensable and non-redundant mechanism that drives lymphatic endothelial cell migration and sprouting, thereby establishing a critical coordination between growth factor and GPCR pathways in lymphatic development.

The Gist

Imagine your body as a bustling city. You have a main highway system (your blood vessels) that delivers oxygen and nutrients to every neighborhood. But cities also need a sanitation and recycling system to handle waste and excess water. In your body, this is the lymphatic system.

For a long time, scientists knew that the "construction manager" for building these lymphatic roads was a signal called Vegfc. Think of Vegfc as the city planner who draws the blueprints and tells the construction crews (cells) where to go.

However, this new study reveals that the city planner isn't working alone. There's a second, crucial signal called Apelin (and its receptor, Aplnr) that acts like the foreman or the traffic cop on the ground. Without this foreman, the construction crews get confused and stop building, even if the city planner gave perfect instructions.

Here is the story of what the researchers discovered, broken down simply:

1. The Problem: The Construction Crews Stopped Moving

The researchers looked at zebrafish embryos (which are great for studying how bodies grow because they are see-through). They found that when the "foreman" signal (Apelin) was missing, the lymphatic roads simply never got built.

• The Analogy: Imagine a construction crew standing at the edge of a river (the main blood vessel). They have their tools and their blueprints, but they just won't jump into the boats to cross the river and build the new road on the other side. They are stuck.
• The Result: Without Apelin, the lymphatic vessels failed to sprout, leaving the body without a drainage system.

2. The Discovery: It's About Movement, Not Identity

A key question was: Did the cells forget what they were supposed to be?

• The Finding: No. The cells knew they were supposed to be lymphatic builders. They just couldn't move.
• The Analogy: It's like a group of actors who know their lines perfectly (they are the right "type" of cell) but are too shy or confused to walk onto the stage. Apelin is the signal that gives them the confidence to step out and start working.

3. The Connection: The City Planner Hires the Foreman

The most exciting part of the study is how these two signals talk to each other.

• The Chain of Command: The researchers found that the main city planner (Vegfc) actually sends a message to the construction crew to hire the foreman (Apelin).
• The Mechanism: When Vegfc signals the cells, it turns on a switch (called ERK) that tells the cells, "Okay, now you need to turn on your Apelin receptors so you can start moving."
• The Analogy: You can't just tell a construction crew to "go build." You have to give them the specific tool (the Apelin receptor) that allows them to respond to the "go" signal. Vegfc hands them the tool; Apelin is the tool that makes them move.

4. What Happens When Things Go Wrong?

• Too Little Apelin: The crew stays stuck at the riverbank. No lymphatic system is built.
• Too Much Apelin: The crew gets too excited. They start building roads everywhere, even in places they shouldn't (like jumping out of the river in random directions). This creates a chaotic, messy network.
• The Balance: The body needs a perfect balance. The city planner (Vegfc) must tell the crew to get ready, and the foreman (Apelin) must tell them exactly when and where to move.

Why Does This Matter?

This is a big deal for medicine.

• The "Druggable" Target: The main signal (Vegfc) is involved in everything—growing blood vessels, healing wounds, and even helping tumors grow. If you try to stop Vegfc to fix a lymphatic problem, you might accidentally stop your heart or brain from getting blood.
• The Solution: Apelin is more specific. It's like a specialized tool just for the lymphatic "foremen." If we can learn to tweak the Apelin signal, we might be able to fix lymphatic diseases (like lymphedema, where limbs swell because fluid can't drain) without messing up the rest of the body's plumbing.

The Bottom Line

Building a lymphatic system isn't just about having a blueprint (Vegfc); it's about having the right foreman (Apelin) to get the crew moving. This study shows that these two signals work together in a tight dance: the blueprint tells the cells to get ready, and the foreman tells them to start walking. Understanding this dance opens up new ways to treat diseases where the body's drainage system fails.

Technical Summary

1. Problem Statement

Lymphangiogenesis, the formation of new lymphatic vessels, is primarily driven by the Vegfc–Vegfr3 (Flt4) signaling axis. While Vegfc is essential for both the specification of lymphatic endothelial cell (LEC) precursors and their subsequent migration, the regulatory mechanisms governing the migratory behavior of these cells remain incompletely understood.

• The Gap: G protein-coupled receptors (GPCRs) are major drug targets, yet their specific roles in lymphatic development are unclear. Previous studies suggested a link between Apelin signaling (via the Apelin receptor, Aplnr) and lymphatic development, but the cellular and molecular mechanisms—specifically how Apelin interacts with the Vegfc pathway—were unknown.
• The Question: Does Apelin signaling regulate LEC specification or migration? How does it mechanistically interact with the Vegfc–Vegfr3 pathway?

2. Methodology

The study utilized zebrafish (Danio rerio) as the primary model organism due to their optical transparency and genetic tractability.

• Genetic Models: The authors employed various transgenic lines (e.g., Tg(kdrl:EGFP), Tg(fli1a:nEGFP), TgBAC(prox1a:KALTA4)) and mutant lines (apln, aplnra, aplnrb, flt4).
• Loss-of-Function: Analysis of apln (ligand) and aplnra/aplnrb (receptor) mutants to assess lymphatic defects.
• Gain-of-Function: Heat-shock inducible overexpression of Apelin (Tg(hsp70l:apln)) and Vegfc (Tg(UAS:vegfc)) to observe ectopic sprouting.
• Rescue Experiments: Tissue-specific re-expression of Apelin in apln mutants using Gal4/UAS systems (vascular, neural, and fibroblast-specific drivers) to determine the functional source of the ligand.
• Live Imaging & Time-Lapse: Confocal microscopy to track LEC sprouting dynamics from the Posterior Cardinal Vein (PCV) in real-time (30–48 hours post-fertilization, hpf).
• Molecular Analysis:
  • scRNA-seq: Analysis of public single-cell datasets to correlate aplnrb expression with lymphatic markers.
  • In Situ Hybridization (WISH): To check expression of vegfc, flt4, and etsrp in mutants.
  • Pathway Manipulation: Mosaic expression of constitutively active MEK (Map2k2b) to activate ERK signaling and assess downstream effects on aplnrb.

3. Key Contributions & Results

A. Apelin Signaling is Essential for LEC Migration, Not Specification

• Phenotype: apln mutant zebrafish fail to form the Thoracic Duct (TD) and show a severe reduction in venous intersegmental vessels (vISVs).
• Specificity: While apln mutants lack lymphatic vessels, the expression of the LEC marker prox1a in the PCV remains normal. This indicates that Apelin is dispensable for LEC specification but indispensable for their migration out of the PCV.
• Receptor Specificity: The phenotype is primarily driven by the Apelin receptor B (aplnrb). Double mutants of aplnra and aplnrb phenocopy the apln ligand mutant, suggesting functional redundancy where aplnrb is dominant.
• Cellular Dynamics: apln mutants exhibit an accumulation of endothelial cells (ECs) within the PCV, confirming a failure in the "budding" or sprouting process rather than cell death or lack of proliferation.

B. Spatiotemporal Regulation of aplnrb

• Expression Pattern: aplnrb is dynamically upregulated in LEC precursors within the PCV starting at 33 hpf, coinciding with the onset of sprouting.
• Correlation: Single-cell RNA sequencing data reveals that aplnrb expression peaks during early lymphatic specification and correlates with pro-migratory genes (egfl7) and lymphatic markers (sox18, flt4), but declines as vessels mature.
• Ligand Sources: Apelin is expressed by fibroblasts at the horizontal myoseptum, neural progenitors, and arterial ECs. However, vascular-derived Apelin (expressed in ECs) was the only source capable of partially rescuing the apln mutant phenotype, highlighting the importance of autocrine/paracrine signaling within the vasculature.

C. Genetic Interaction with Vegfc–Vegfr3

• No Transcriptional Regulation: apln mutants show normal expression of vegfc, flt4, and etsrp, indicating Apelin does not regulate Vegfc signaling at the transcriptional level.
• Synergy: Double heterozygous mutants (apln+/-; flt4+/-) exhibit severe defects (complete loss of TD), suggesting a synergistic genetic interaction.
• Dependency: Overexpression of Vegfc normally induces ectopic sprouting. However, this hypersprouting phenotype is abolished in apln mutants, proving that Vegfc-induced sprouting is dependent on Apelin signaling.

D. Mechanistic Link: Vegfc $\rightarrow$ ERK $\rightarrow$ Aplnrb

• Upregulation: Overexpression of Vegfc leads to a specific upregulation of aplnrb expression in the PCV.
• ERK Pathway: This upregulation is mediated by the ERK/MAPK pathway. Mosaic activation of ERK (via constitutively active Map2k2b) in ECs is sufficient to induce aplnrb expression.
• The Model: Vegfc signaling activates ERK, which in turn upregulates aplnrb expression in LEC precursors. This renders the cells competent to respond to Apelin's pro-migratory cues, driving them out of the PCV.

4. Significance

• Novel Regulatory Axis: The study establishes a critical signaling axis where the growth factor pathway (Vegfc–Vegfr3) primes cells for migration by upregulating a GPCR pathway (Apelin–Aplnrb) via ERK.
• Therapeutic Implications: Since Apelin signaling specifically regulates migration without affecting initial cell specification, it represents a targetable therapeutic entry point. Modulating Apelin could potentially treat lymphatic disorders (e.g., lymphedema) or inhibit pathological lymphangiogenesis (e.g., cancer metastasis) without disrupting the broader, essential functions of Vegfc signaling in vascular maintenance.
• Mechanistic Insight: It resolves the "how" of lymphatic sprouting, demonstrating that growth factor signaling alone is insufficient; it must be coupled with GPCR-mediated migration cues to drive vessel formation.

Conclusion

The authors propose a model where Vegfc–Vegfr3 signaling drives LEC specification and, via ERK activation, induces the expression of Aplnrb. This upregulation allows LECs to respond to Apelin ligands, which act as the critical driver for the migration and sprouting of lymphatic vessels from the venous niche. This coordinated mechanism ensures precise spatiotemporal control of lymphatic development.